由美特福林调节的葡萄糖流从循环流向肠道光层
Kazuhiko Sakaguchi1,2, Kenji Sugawara1, Yusei Hosokawa1
1Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Communications medicine
|March 3, 2025
概括
甲福明显著增加了葡萄糖在肠道中的分泌,这是一个以前未知的途径,可能会影响肠道微生物群和宿主共生. 这种肠道葡萄糖流是甲福林的潜在机制.
科学领域:
- * 内分泌学 在内分泌学.
- * 胃肠病学 胃肠病学
- * 代谢过程中的代谢.
背景情况:
- 众所周知,甲胺会增加肠道光层中的FDG积累,这表明葡萄糖分泌量增加.
- 甲胺诱导的肠道葡萄糖分泌的确切机制和动态尚不清楚.
- 了解这种现象对于阐明甲胺的作用及其对肠道生理学的影响至关重要.
研究的目的:
- 为了研究肠道葡萄糖分泌的详细动态.
- 量化葡萄糖分泌速度并分析分泌葡萄糖的新陈代谢.
- 为了比较2型糖尿病患者用和不用甲福林治疗的个体中的这些动态.
主要方法:
- 利用新的FDG PET-MRI生物成像来量化2型糖尿病患者的肠道葡萄糖分泌量.
- 在静脉注射13C标记葡萄糖后,使用质谱测量分析了小鼠的便样本.
- 在甲福明治疗的背景下研究葡萄糖代谢.
主要成果:
- FDG PET/MRI 确定了阴作为葡萄糖分泌的部位.
- 接受甲胺治疗的个体显示出显著的葡萄糖分泌 (~1.65 g/h/body) 进入肠道光层.
- 非甲胺的个体也表现出生理性葡萄糖分泌 (~0.41 g/h/body),甲胺增加了小鼠在便中加入13C的SCFA.
结论:
- 从循环到肠道光层存在大量的,以前未被识别的葡萄糖流.
- 这种葡萄糖流可能在肠道微生物群与宿主共生中起作用.
- 肠道葡萄糖分泌是甲福明在人类中的作用的潜在治疗点.
相关概念视频
Glucose Absorption Into the Small Intestine
31.2K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.2K
Transcellular Transport of Solutes
3.4K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.4K
Glucose Homeostasis: Regulation of Blood Glucose
1.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.4K
Hormones Regulating Blood Glucose
3.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.0K
Carbohydrate Absorption
412
Carbohydrates are essential macronutrients that serve as the body's primary energy source. Their digestion begins in the mouth, where salivary amylase partially breaks down complex carbohydrates such as starch into smaller oligosaccharides. This mechanical and enzymatic activity prepares carbohydrates for further processing in the gastrointestinal tract.
After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...
After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...
412
Oral Hypoglycemic Agents: Biguanides and Glitazones
151
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
151


